Literature DB >> 17400610

Protection of CD8+ T cells from activation-induced cell death by IL-18.

Wen Li1, Shin-Ichiro Kashiwamura, Haruyasu Ueda, Atsuo Sekiyama, Haruki Okamura.   

Abstract

Role of IL-18 on proliferation and survival of CD8+ T cells, activated by immobilized anti-CD3 antibody (anti-CD3), was examined. Proliferation and survival of activated T cells, especially that of CD8+ T cells, were impaired by IL-18 deficiency [IL-18 knockout (KO)]. After 3 days of culture with anti-CD3, the number of living CD8+ T cells from IL-18KO mice was approximately 25% of that from wild-type (WT) mice but was increased to the same level as WT cells by the addition of IL-18. The expression of IL-18 receptors (IL-18Rs), particularly IL-18Rbeta chain, in naïve CD8+ T cells was very low but elevated after stimulation with anti-CD3. Blockade of IL-18R by anti-IL-18R antibody on activated WT CD8+ T cells resulted in reduction of living cells, suggesting that IL-18 promotes survival of proliferating CD8+ T cells. Levels of Bcl-2 in activated IL-18KO CD8+ T cells were lower than those in WT cells but were raised by exogenous IL-18. Blockade of IL-18R on WT CD8+ T cells decreased the expression of surface markers CD122 and CD94, which are related to cell viability, and the expression of these markers was increased by exogenous IL-18 in IL-18KO cells. These results suggest that IL-18 acts directly on activated CD8+ T cells through IL-18Rs and promotes their survival to expand the population.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17400610     DOI: 10.1189/jlb.0706431

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  11 in total

1.  Modulation of γδ T-cell activation by neutrophil elastase.

Authors:  Nadia Yasmín Towstyka; Carolina Maiumi Shiromizu; Irene Keitelman; Florencia Sabbione; Gabriela Verónica Salamone; Jorge Raúl Geffner; Analía Silvina Trevani; Carolina Cristina Jancic
Journal:  Immunology       Date:  2017-10-05       Impact factor: 7.397

2.  PEGylated IL-10 (Pegilodecakin) Induces Systemic Immune Activation, CD8+ T Cell Invigoration and Polyclonal T Cell Expansion in Cancer Patients.

Authors:  Aung Naing; Jeffrey R Infante; Kyriakos P Papadopoulos; Ivan H Chan; Cong Shen; Navneet P Ratti; Bianca Rojo; Karen A Autio; Deborah J Wong; Manish R Patel; Patrick A Ott; Gerald S Falchook; Shubham Pant; Annie Hung; Kara L Pekarek; Victoria Wu; Matthew Adamow; Scott McCauley; John B Mumm; Phillip Wong; Peter Van Vlasselaer; Joseph Leveque; Nizar M Tannir; Martin Oft
Journal:  Cancer Cell       Date:  2018-11-12       Impact factor: 31.743

3.  Cytotoxic potential of lung CD8(+) T cells increases with chronic obstructive pulmonary disease severity and with in vitro stimulation by IL-18 or IL-15.

Authors:  Christine M Freeman; MeiLan K Han; Fernando J Martinez; Susan Murray; Lyrica X Liu; Stephen W Chensue; Timothy J Polak; Joanne Sonstein; Jill C Todt; Theresa M Ames; Douglas A Arenberg; Catherine A Meldrum; Christi Getty; Lisa McCloskey; Jeffrey L Curtis
Journal:  J Immunol       Date:  2010-04-28       Impact factor: 5.422

4.  Inflammasome and Inflammatory Programmed Cell Death in Chromoblastomycosis.

Authors:  Carla Pagliari; Luciane Kanashiro-Galo; Mirian Nacagami Sotto
Journal:  Mycopathologia       Date:  2022-10-23       Impact factor: 3.785

5.  MyD88 plays a critical T cell-intrinsic role in supporting CD8 T cell expansion during acute lymphocytic choriomeningitis virus infection.

Authors:  Adeeb H Rahman; Weiguo Cui; David F Larosa; Devon K Taylor; Jidong Zhang; Daniel R Goldstein; E John Wherry; Susan M Kaech; Laurence A Turka
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

Review 6.  Anti-viral CD8 T cells and the cytokines that they love.

Authors:  Maureen A Cox; Shannon M Kahan; Allan J Zajac
Journal:  Virology       Date:  2013-01-05       Impact factor: 3.616

7.  Exhausted CD8 T cells downregulate the IL-18 receptor and become unresponsive to inflammatory cytokines and bacterial co-infections.

Authors:  Jennifer T Ingram; John S Yi; Allan J Zajac
Journal:  PLoS Pathog       Date:  2011-09-29       Impact factor: 6.823

8.  Adjuvant effects of recombinant giant panda (Ailuropoda melanoleuca) IL-18 on the canine distemper disease vaccine in mice.

Authors:  Yue Yan; Lili Niu; Jiabo Deng; Qiang Wang; Jianqiu Yu; Yizheng Zhang; Jianxi Wang; Jiao Chen; Changhe Wei; Xuemei Tan
Journal:  J Vet Med Sci       Date:  2014-11-14       Impact factor: 1.267

Review 9.  Immune regulation and cytotoxic T cell activation of IL-10 agonists - Preclinical and clinical experience.

Authors:  Martin Oft
Journal:  Semin Immunol       Date:  2019-11-06       Impact factor: 11.130

10.  Regulation of development of CD56 bright CD11c + NK-like cells with helper function by IL-18.

Authors:  Wen Li; Akico Okuda; Hideyuki Yamamoto; Kyosuke Yamanishi; Nobuyuki Terada; Hiromichi Yamanishi; Yoshimasa Tanaka; Haruki Okamura
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.